J Diabetes Investig 2018;9: 311--320

Introduction {#jdi12704-sec-0005}
============

Diabetes mellitus is an increasingly prevalent disease[1](#jdi12704-bib-0001){ref-type="ref"}, [2](#jdi12704-bib-0002){ref-type="ref"}. Early glycemic control is important because strict control in the late stage of diabetes mellitus yields reduced protective results[3](#jdi12704-bib-0003){ref-type="ref"}, [4](#jdi12704-bib-0004){ref-type="ref"}, [5](#jdi12704-bib-0005){ref-type="ref"}, [6](#jdi12704-bib-0006){ref-type="ref"}.

However, patients often delay insulin treatment[7](#jdi12704-bib-0007){ref-type="ref"}. The reluctance to initiate insulin[8](#jdi12704-bib-0008){ref-type="ref"}, [9](#jdi12704-bib-0009){ref-type="ref"}, [10](#jdi12704-bib-0010){ref-type="ref"} and its subsequent titration[11](#jdi12704-bib-0011){ref-type="ref"} is termed psychological insulin resistance (PIR).

Despite the high prevalence of PIR, doctors, and especially those working in the primary care arena, often incorrectly estimate the reasons for PIR among patients (e.g., most nurses and primary care doctors underestimate of the number of patients who blame themselves for needing to use insulin)[10](#jdi12704-bib-0010){ref-type="ref"}. In the large‐scale Diabetes Attitudes, Wishes and Needs (DAWN) study, involving more than 5,000 diabetes mellitus patients and nearly 4,000 healthcare professionals, the comments included "less than half the health care professionals interviewed felt able to identify and evaluate patients' psychological needs" and "...emotions are not always perceived or addressed adequately by health care providers"[12](#jdi12704-bib-0012){ref-type="ref"}.

The Insulin Treatment Appraisal Scale (ITAS) was developed to identify the reasons for PIR among patients, to monitor changes in the appraisal of insulin treatment, and to aid in patient education and counseling[13](#jdi12704-bib-0013){ref-type="ref"}. The instrument, consisting of four positive and 16 negative statements (2‐dimensional instrument with "appraisal of insulin therapy" as a single underlying construct), was developed and validated in the USA.

The ITAS has been used by researchers worldwide to understand PIR in different populations (e.g., in primary care in Amsterdam[9](#jdi12704-bib-0009){ref-type="ref"}, in Egypt[14](#jdi12704-bib-0014){ref-type="ref"}, in a German geriatric population[15](#jdi12704-bib-0015){ref-type="ref"} and in Romania[16](#jdi12704-bib-0016){ref-type="ref"}), to study the relationship of PIR with depression[9](#jdi12704-bib-0009){ref-type="ref"}, [17](#jdi12704-bib-0017){ref-type="ref"} and to investigate changes in PIR after the use of different types of insulin or insulin delivery methods[18](#jdi12704-bib-0018){ref-type="ref"}, [19](#jdi12704-bib-0019){ref-type="ref"}, or after specific programs (e.g., team approaches involving diabetes nurses/endocrinologists)[20](#jdi12704-bib-0020){ref-type="ref"}. The ITAS has been found to be sensitive to changes in PIR throughout the course of diabetes mellitus[21](#jdi12704-bib-0021){ref-type="ref"}.

The ITAS was translated and validated in Taiwan[22](#jdi12704-bib-0022){ref-type="ref"}, [23](#jdi12704-bib-0023){ref-type="ref"} (C‐ITAS). Subsequently, a Hong Kong (HK) study[24](#jdi12704-bib-0024){ref-type="ref"} that examined the relationship between psychosocial factors and PIR using the C‐ITAS identified a possible translation issue with at least one ITAS statement. Because of language and cultural differences between Hong Kong and Taiwanese populations, validation of the ITAS in HK is warranted.

The present study aimed to examine and modify the C‐ITAS, and to validate the use of the modified version in HK primary care. A validated version could be applied clinically to identify and detect the reasons for PIR, and to facilitate the comparison of HK PIR data with those of other countries.

Methods {#jdi12704-sec-0006}
=======

The translation and validation process followed published guidelines[25](#jdi12704-bib-0025){ref-type="ref"}. This research was approved by the ethics committee of the Kowloon West Cluster, HK Hospital Authority.

ITAS questionnaire {#jdi12704-sec-0007}
------------------

The ITAS, in its original version and in its Chinese translation, the C‐ITAS, is a 20‐item instrument that contains 16 negative and four positive statements that appraise insulin treatment. Each statement is ranked using a five‐point Likert‐type scale from 1 to 5. Positive scores are reversed to allow for summation. The total possible score ranges from 0 to 80. A higher score signifies a more negative appraisal of insulin. The total scores of the positive and negative subscales can be calculated by summing the scores of the four positive and 16 negative statements, respectively.

The original Taiwan Chinese version of the C‐ITAS questionnaire was back‐translated into English by two bilingual primary care doctors and one layman, who was an architect. The primary care doctors and the architect were local Chinese who obtained bachelor degrees using English as the primary language. They were blind to the English version of the ITAS. The C‐ITAS was used as the first step to allow comparison of C‐ITAS data with data from other Asian regions (e.g., Taiwan)

The ITAS questionnaires back‐translated by the doctors (BT1) and the layman (BT2) were compared by a committee composed of nine family medicine (FM) doctors, the translators and the principle investigator. These individuals were bilingual, and all of the doctors had experience in prescribing insulin. They rated the comparability of the language and the similarity of the interpretation of BT1/BT2 with the original English version. All of the non‐equivalent items were modified by the committee to enhance their translational equivalence to the original English version (in terms of sentence structure, meaning and wording) until equivalence was achieved, resulting in the modified questionnaire (ITAS‐1).

The ITAS‐1 was pilot tested by interviewing 10 diabetes mellitus patients, who were randomly selected at an outpatient clinic (East Kowloon General Outpatient Clinic) during their diabetes mellitus follow‐up visits. Any wording or statement that the patients did not understand was clarified, and potential improvements were reported. The instructions, response format and items of the instruments that were found to be unclear by at least 20% of the sample population were re‐evaluated[25](#jdi12704-bib-0025){ref-type="ref"}. Any questions that could not be clarified by the committee were sent to the developer for clarification, resulting in a second modified questionnaire (ITAS‐2)[25](#jdi12704-bib-0025){ref-type="ref"}.

The ITAS‐2 was further evaluated by an expert panel composed of two endocrinologists, two specialized diabetes nurses, one FM professor, two FM specialists and two FM doctors. The questionnaire was evaluated for its conceptual equivalence (clarity), and each member who rated the instructions, response format or any item of the instruments as unclear was asked to provide suggestions for rewriting the statements and clarifying the language. Any instructions, response formatting or items of the instruments that were found to be unclear by at least 20% of the members were revised and re‐evaluated[25](#jdi12704-bib-0025){ref-type="ref"}.

The expert panel was then asked to evaluate each item for contact equivalence (relevancy) using the following scale: 1, not relevant; 2, unable to assess relevance; 3, relevant but needs minor alteration; and 4, very relevant and succinct. The content equivalence index values at the item level (I‐CVI) and scale level (S‐CVI) were calculated through averaging. The minimum accepted I‐CVI value was 0.78, whereas the minimum accepted S‐CVI value was 0.9[25](#jdi12704-bib-0025){ref-type="ref"}. Any item that did not fulfill the index criterion was revised and re‐evaluated[25](#jdi12704-bib-0025){ref-type="ref"}. Interrater reliability was calculated by the Kappa coefficient of agreement[25](#jdi12704-bib-0025){ref-type="ref"}.

The finalized version (C‐ITAS‐HK) was then subjected to psychometric testing in a sample of patients[25](#jdi12704-bib-0025){ref-type="ref"}.

Patients {#jdi12704-sec-0008}
--------

The study was carried out in 10 government‐funded general outpatient clinics in the Kowloon West Cluster in Hong Kong from July to September 2015. We aimed to recruit a representative sample of diabetes mellitus patients who regularly followed up in Hong Kong government‐funded clinics, where most patients (\>87%) with chronic diseases have their regular follow ups. A recruitment period of 3 months was selected, because most diabetes mellitus patients receive follow up at 3‐month intervals[26](#jdi12704-bib-0026){ref-type="ref"}.

Using a criterion of 10 participants per question, a sample size of 200 was required. Considering a dropout rate of 40%, 333 participants were recruited. Patients who were diagnosed with type 2 diabetes according to the World Health Organization criteria[27](#jdi12704-bib-0027){ref-type="ref"}, aged \>18 years and Chinese were recruited consecutively by diabetes mellitus nurses when they came in for counseling, annual checks or blood tests. As the questionnaires can be self‐administered, only patients who could read and write in Chinese were recruited. The exclusion criteria were a current pregnancy, illiteracy, or severe mental or physical illness that prevented completion of the questionnaire.

Measurements {#jdi12704-sec-0009}
------------

Sociodemographic data were input by the patient. The patients were asked if their doctors had suggested insulin to them previously, if their relatives were using insulin, and if they lived with family members. Clinical data, including glycosylated hemoglobin (HbA1c) levels, low‐density lipoprotein levels, the duration of diabetes mellitus, the presence of impaired foot vibration sense, the presence of retinopathy requiring referral to a specialist, the presence of an impaired estimated glomerular filtration rate (\<60) and the presence of microalbuminuria, were retrieved from medical records.

All of the patients were asked if they were willing to begin insulin treatment (or to titrate insulin if already on insulin treatment) if suggested by their case doctors. Their answers were recorded on a Likert‐scale of "very unwilling," to "unwilling," to "willing," to "very willing." Participants who chose "very unwilling" or "unwilling" were defined as "subjects with PIR."

A total of 22 participants were contacted by telephone to repeat the ITAS questionnaire approximately 4 weeks after the initial interview to assess test--retest reliability.

Statistical analysis {#jdi12704-sec-0010}
--------------------

IBM SPSS Statistics for Windows version 22 (IBM, Armonk, NY, USA) was used for statistical analysis. The frequency, mean, median and standard deviation were calculated with descriptive statistics for all measures. Comparisons among various demographic categories, and between participants with and without PIR and ITAS scores were made using χ[2](#jdi12704-bib-0002){ref-type="ref"}‐tests for categorical data and *t*‐tests for continuous data.

Exploratory factor analysis with oblimin rotation was carried out on the 20 ITAS items. Oblimin rotation was used in the original validation study[13](#jdi12704-bib-0013){ref-type="ref"} for statements that the authors believed were related. The Kaiser criterion (eigenvalue \>1) and the scree plot of eigenvalues were used to determine the optimal number of factors

Internal consistency was examined by calculating Cronbach\'s alpha, item total correlations and inter‐item correlations. An internal consistency of 0.7--0.8 was defined as satisfactory, and the item total correlation was defined as desirable if the value was \>0.20. An inter‐item correlation \>0.80 indicated redundancy.

Results {#jdi12704-sec-0011}
=======

Development of the C‐ITAS‐HK {#jdi12704-sec-0012}
----------------------------

Before and during pilot testing with patients, any identified discrepancy was resolved by the committee. However, participants had difficulty in understanding the meaning of "flexible" (ITAS statement 5), which the committee could not resolve. Clarification by the original developer was sought by e‐mail exchange, and the statement was later translated to "life being more restricted."

The finalized C‐ITAS‐HK was agreed on by the expert panel, with the I‐CVI ranging from 0.83 to 1.00 and an S‐CVI of 0.97. The interrater reliability was high, with a coefficient of 0.894 (95% confidence interval 0.760--0.972).

Participants {#jdi12704-sec-0013}
------------

A total of 333 patients from 10 different clinics were recruited; 18 individuals refused to participate. One questionnaire was invalidated, as all of the answers were "neutral." The response rate was 94.3%.

The respondents' demographic data can be found in Table[1](#jdi12704-tbl-0001){ref-type="table-wrap"}. The non‐respondents were not significantly different from the respondents in terms of sex, the presence of complications, treatment modality, education level, HbA1c level, low‐density lipoprotein level or age (Table[1](#jdi12704-tbl-0001){ref-type="table-wrap"}). However, the non‐respondents showed a relatively shorter duration of diabetes mellitus (3.17 years vs 8.31 years; *P* \< 0.001)

###### 

Respondent and non‐respondent characteristics

                                  Respondents   Non‐respondents   *P*‐value
  ------------------------------- ------------- ----------------- ------------------------------------------------
  Mean age (years)                                                
  Age                             63.29         64.23             0.743
  Age distribution (%)                                            
  ≤50                             11.2          7.7               0.929
  51--60                          25.6          30.8              
  61--70                          41.5          46.2              
  71--80                          17.3          7.7               
  \>80                            4.5           7.7               
  Sex (%)                                                         
  Male                            45.3          58.3              0.375
  Female                          54.7          41.7              
  Marriage status (%)                                             
  Married                         76.1                            
  Single                          10.5                            
  Divorced                        5.9                             
  Widowed                         7.5                             
  Employment status (%)                                           
  Working                         35.9          42.9              0.497
  Unemployed                      5.8           0                 
  Retired                         58.3          57.1              
  Education (%)                                                   
  No education                    7.3           8.3               0.826
  Primary level                   39.8          50                
  Secondary level                 43            3.6               
  University level                8.6           0                 
  Master\'s or above              1.3           0                 
  Relative on insulin (%)                                         
  Yes                             27.6                            
  Lived with family (%)                                           
  Yes                             88.3                            
  Monthly family income (%)                                       
  \<\$5,000                       31.2                            
  \$5,001--10,000                 20                              
  \$10,001--20,000                26.8                            
  \$20,001--30,000                15.6                            
  \>\$30,000                      6.4                             
  DM complications (%)                                            
  MDRD \<60                       14.8          25                0.336
  Microalbuminuria                17.4          25                0.5
  Retinopathy                     9.8           8.3               0.869
  Impaired foot vibration sense   1.0           8.3               0.143
  Tx modality (%)                                                 
  Insulin                         5.8           0                 1.0
  Oral drugs                      84.2          91.7              0.7
  Diet alone                      15.4          8.3               1.0
  HbA1c (%)                                                       
  Mean value                      7.26          7.25              0.967
  HbA1c ≤7%                       49.7          66.7              0.378
  LDL                                                             
  Mean value                      2.51          2.76              0.256
  ≤2.6? (%)                       62.5          50                0.383
  Years of Dx of DM                                               
  ≤10 years (%)                   70.7          100               0.023[a](#jdi12704-note-0101){ref-type="fn"}
  Mean value                      8.31          3.17              \<0.001[a](#jdi12704-note-0101){ref-type="fn"}

Missing data from non‐respondents were due to a lack of information from the medical records system. DM, diabetes mellitus; Dx, duration; HbA1c, glycosylated hemoglobin; LDL, low‐density lipoprotein; MDRD, estimated glomerular filtration rates by Modification of Diet in Renal Disease formula; Tx, treatment.

\**P* \< 0.05.

John Wiley & Sons, Ltd

The prevalence of PIR among participants who had never used insulin before (insulin‐naive participants) was 63.1%, whereas that among insulin users was 29.4%.

Factor analysis {#jdi12704-sec-0014}
---------------

Exploratory factor analyses revealed four factors with an eigenvalue \>1. The first four eigenvalues were 6.04, 2.12, 1.35 and 1.15, which explained 30.2%, 40.79%, 47.55% and 53.3% of the variance, respectively. The "knick" in the scree plot suggested a two‐ or three‐factor structure. The one‐, two‐, three‐ and four‐factor solutions were generated by principle axis factoring with oblimin oblique rotation (Table[2](#jdi12704-tbl-0002){ref-type="table-wrap"} ).

###### 

Exploratory factor analyses of the 20 items of the Insulin Treatment Appraisal Scale: forced one‐ to four‐factor solutions after oblimin rotation and a two‐factor solution excluding question 1

                                               One‐factor solution   Two‐factor solution   Three‐factor solution                                           
  -------------------------------------------- --------------------- --------------------- ----------------------- ------- ------- ------- ------- ------- ---------
  Item content                                                                                                                                             
  1\. Failed on pre‐insulin therapy            0.72                                        0.209                           0.365   0.324           0.397   
  2\. Diabetes has gotten worse                0.112                 0.334                 0.234                   0.342   0.342   0.456   0.356   0.397   --0.413
  3\. Prevent complications                    0                                           0.248                           0.498   0.281           0.493   
  4\. Perceived by others as more sick         0.205                 0.453                 0.213                   0.453           0.309   0.461           
  5\. Life less flexible                       0.411                 0.641                 0.42                    0.641           0.417   0.64            
  6\. Fear of injecting with needle            0.229                 0.479                 0.238                   0.479           0.276   0.481           
  7\. Risk of hypoglycemia                     0.165                 0.406                 0.206                   0.409           0.204   0.408           
  8\. Improves health                          0.001                                       0.262                           0.51    0.359           0.528   
  9\. Causes weight gain                       0.113                 0.336                 0.114                   0.336           0.114   0.335           
  10\. Takes time and energy                   0.431                 0.656                 0.438                   0.656           0.449   0.656           
  11\. Give up activities I enjoy              0.544                 0.737                 0.543                   0.736           0.541   0.734           
  12\. My health will deteriorate              0.402                 0.634                 0.405                   0.633           0.435   0.636           
  13\. Injecting is embarrassing               0.507                 0.712                 0.508                   0.711           0.506   0.709           
  14\. Injecting is painful                    0.371                 0.609                 0.371                   0.608           0.402   0.61            
  15\. Difficult to always inject correctly    0.481                 0.693                 0.521                   0.697           0.568   0.701           
  16\. Difficult to fulfill responsibilities   0.608                 0.78                  0.646                   0.784           0.667   0.785           
  17\. Helps to control blood glucose          0.003                                       0.414                           0.641   0.39            0.619   
  18\. Family/friends more concerned           0.532                 0.729                 0.533                   0.728           0.531   0.726           
  19\. Helps to improve energy levels          0.057                                       0.142                                   0.222                   
  20\. More dependent on doctor                0.214                 0.462                 0.227                   0.462           0.237   0.462           
  Explained variance (%)                                             30.2                                          40.79                   47.55           

                                               Four‐factor solution   Two‐factor solution (without Q1)                                            
  -------------------------------------------- ---------------------- ---------------------------------- ------- -------- ------- ------- ------- -------
  Item content                                                                                                                                    
  1\. Failed on pre‐insulin therapy            0.318                                                     0.392                                    
  2\. Diabetes has gotten worse                0.435                                                                              0.229   0.317   
  3\. Prevent complications                    0.279                                                     0.493                    0.292           0.541
  4\. Perceived by others as more sick         0.361                  0.464                                      −0.323           0.201   0.446   
  5\. Life less flexible                       0.415                  0.638                                                       0.415   0.637   
  6\. Fear of injecting with needle            0.338                  0.485                                                       0.246   0.479   
  7\. Risk of hypoglycemia                     0.297                  0.414                                                       0.2     0.403   
  8\. Improves health                          0.37                                                      0.532                    0.298           0.544
  9\. Causes weight gain                       0.235                  0.342                                               0.341   0.113   0.335   
  10\. Takes time and energy                   0.482                  0.658                                                       0.437   0.659   
  11\. Give up activities I enjoy              0.559                  0.735                                                       0.548   0.74    
  12\. My health will deteriorate              0.472                  0.639                                                       0.404   0.632   
  13\. Injecting is embarrassing               0.506                  0.708                                                       0.508   0.712   
  14\. Injecting is painful                    0.47                   0.616                                                       0.388   0.61    
  15\. Difficult to always inject correctly    0.569                                                                              0.515   0.702   
  16\. Difficult to fulfill responsibilities   0.674                  0.784                                                       0.642   0.789   
  17\. Helps to control blood glucose          0.404                                                     0.623                    0.401           0.629
  18\. Family/friends more concerned           0.544                  0.726                                                       0.535   0.731   
  19\. Helps to improve energy levels          0.217                                                                              0.172           0.334
  20\. More dependent on doctor                0.255                  0.463                                                       0.237   0.463   
  Explained variance (%)                                              53.3                                                                41.86   

Only factors with a loading \>0.3 are shown. F, factor; h2, communality; Q1 question 1.

John Wiley & Sons, Ltd

In the one‐factor solution, all of the positive statements and the question 1 item "failed on pre‐insulin therapy" failed to load sufficiently. In the three‐factor solution, the only difference from the two‐factor solution was found for question 2 "diabetes has gotten worse," which loaded on all three factors and was the sole statement in factor three. In the four‐factor solution, only question 4 "perceived by others as sicker" and question 9 "causes weight gain" were loaded on the third and fourth factors, respectively.

Given the minimal additional variance explained by the three‐ or four‐factor solutions and the fact that grouping was not improved in the three‐ to four‐factor solutions, a two‐factor solution was concluded to provide the best representation of the latent structure of the ITAS.

Within the two‐factor solution, using a loading of \>0.4 as a criterion (which was used in the original study in which the instrument was developed[13](#jdi12704-bib-0013){ref-type="ref"}), question 1 "failed on pre‐insulin therapy" and Q2 "diabetes has gotten worse" loaded on both factors, whereas question 9 "causes weight gain" and question 19 "helps to improve energy levels" did not load on either factor.

As the negative statement question 1 "failed on pre‐insulin therapy" was the only statement that was loaded with other positive statements, it was removed, and the two‐factor solution was re‐generated. All of the positive statements were then loaded on factor two, and all of the negatively worded statements were loaded on factor one (Table[2](#jdi12704-tbl-0002){ref-type="table-wrap"} ).

Internal consistency {#jdi12704-sec-0015}
--------------------

Cronbach\'s alpha was 0.846 for the 20‐item scale; 0.882 for the 16‐item, negatively worded item scale; and 0.619 for the 4‐item, positively worded ITAS scale.

For the 20‐item scale, Cronbach\'s alpha was improved when the few positively worded statements were removed: questions 3, 8, 17, and 19 showed low item total scores of 0.116, 0.064, 0.073 and --0.160, respectively, and their removal yielded higher alpha values of 0.851, 0.852, 0.851 and 0.859, respectively. The item total scores of the other questions ranged from 0.315 to 0.659.

For the 16‐item scale, Cronbach\'s alpha was only minimally improved from 0.882 to 0.885 when question 1 was removed. The item total score for question 1 was 0.286.

For the four‐item positive scale, removal of any item resulted in a lower Cronbach\'s alpha.

Discriminant validity {#jdi12704-sec-0016}
---------------------

The ITAS scores were compared between participants with and without PIR, and between participants who were using insulin and those who were insulin‐naive. Patients receiving insulin treatment are known to show a lower PIR[13](#jdi12704-bib-0013){ref-type="ref"}, [21](#jdi12704-bib-0021){ref-type="ref"}. The ITAS scores between these groups were all significantly different in the expected direction, suggesting good discriminant validity (Table[3](#jdi12704-tbl-0003){ref-type="table-wrap"}).

###### 

Insulin Treatment Appraisal Scale scores

                                                                  Insulin users   Non‐insulin users   *P*‐value
  --------------------------------------------------------------- --------------- ------------------- -----------
  Scores of patients treated with insulin and non‐insulin users                                       
  Total ITAS score                                                26.28           37.36               \<0.001
  16‐item negative scale score                                    41.94           51.17               \<0.001
  4‐item positive scale score                                     15.67           13.74               \<0.001

                                            PIR --ve   PIR +ve   *P*‐value
  ----------------------------------------- ---------- --------- -----------
  Scores of patients with and without PIR                        
  Total ITAS score                          32.56      40.33     \<0.001
  16‐item negative scale score              47.09      53.78     \<0.001
  4‐item positive scale score               14.49      13.29     \<0.001

--ve, negative; +ve, positive; ITAS, Insulin Treatment Appraisal Scale; PIR, psychological insulin resistance.

John Wiley & Sons, Ltd

Test--retest reliability {#jdi12704-sec-0017}
------------------------

The Pearson correlation for individual statements ranged from 0.008 to 0.869. The correlation for the total ITAS score, negative‐scale score and positive‐scale score ranged from moderate to strong, at 0.871, 0.782 and 0.692, respectively (Table[4](#jdi12704-tbl-0004){ref-type="table-wrap"}).

###### 

Test--retest reliability, Insulin Treatment Appraisal Scale statements and different social/treatment groups

  Item content                                 Test--retest reliability   On insulin? (%)   PIR +ve? (%)   Lives with family? (%)                                                       
  -------------------------------------------- -------------------------- ----------------- -------------- ------------------------ --------- ------- ------- --------- ------- ------- -------
  1\. Failed on pre‐insulin therapy            0.313                      0.198                                                                                                         
  2\. Diabetes has gotten worse                0.512                      0.054                                                                                                         
  3 Prevent complications                      0.656                      0.011             94.4           62.5                     0.003     75.3    55.2    0.001                     
  4\. Perceived by others as sicker            0.293                      0.217                                                                                                         
  5\. Life less flexible                       0.566                      0.035             16.7           61                       \<0.001   52.6    66      0.033                     
  6\. Fear of injecting with needle            0.4                        0.125             38.9           70.4                     0.005     58.8    77.9    0.001     66.1    88.6    0.004
  7\. Risk of hypoglycemia                     0.499                      0.06                                                                                                          
  8\. Improves health                          0.591                      0.023             59.2           88.9                     0.008     72.6    51.8    0.001                     
  9\. Causes weight gain                       0.428                      0.105                                                               5.2     17.7    0.004     11.9    30.6    0.002
  10\. Takes time and energy                   0.723                      0.002             16.7           45.9                     0.012     27.8    55.8    \<0.001                   
  11\. Give up activities I enjoy              0.562                      0.036                                                               18.9    41.6    \<0.001                   
  12\. My health will deteriorate              0.779                      0.001                                                               31.3    49.4    0.004                     
  13\. Injecting is embarrassing               0.643                      0.011                                                               18.6    50.6    \<0.001                   
  14\. Injecting is painful                    0.523                      0.053                                                               28.1    57.1    \<0.001                   
  15\. Difficult to always inject correctly    0.869                      \<0.001           11.1           53.8                     \<0.001   38.9    63.8    \<0.001                   
  16\. Difficult to fulfill responsibilities   0.817                      \<0.001           16.7           41.6                     0.028     24.5    53.7    \<0.001                   
  17\. Helps to control blood glucose          0.008                      0.493             94.4           70.4                     0.018     86.5    61.4    \<0.001                   
  18\. Family/friends more concerned           0.699                      0.004             16.7           51                       0.004     40.6    59.6    0.003                     
  19\. Helps to improve energy levels          0.369                      0.15              50             23.5                     0.012     37.9    16.3    \<0.001                   
  20\. More dependent on doctor                0.51                       0.055             22.2           47.4                     0.031                                               
  Scoring                                                                                                                                                                               
  Total item score mean                        0.817                      \<0.001           26.28          37.36                    \<0.001   32.56   40.33   \<0.001   36.32   39.32   0.04
  Negative 16‐item score mean                  0.782                      0.001             41.94          51.17                    \<0.001   47.09   53.78   \<0.001   50.22   53.56   0.02
  Positive 4‐item score mean                   0.692                      \<0.001           15.67          13.73                    \<0.001   14.49   13.29   \<0.001                   

  Item content                                       Married? (%)   Relative(s) on insulin? (%)   Sex (%)                                       
  -------------------------------------------- -- -- -------------- ----------------------------- --------- ------ ------ ------- ------ ------ ---------
  1\. Failed on pre‐insulin therapy                                                                                                             
  2\. Diabetes has gotten worse                                                                                                                 
  3 Prevent complications                                                                                                                       
  4\. Perceived by others as sicker                                                                                                             
  5\. Life less flexible                                                                                                                        
  6\. Fear of injecting with needle                  65.1           80.6                          0.013                           58.9   76.8   0.001
  7\. Risk of hypoglycemia                                                                                                                      
  8\. Improves health                                                                                                                           
  9\. Causes weight gain                             10.4           24.7                          0.002                                         
  10\. Takes time and energy                                                                                                                    
  11\. Give up activities I enjoy                                                                                                               
  12\. My health will deteriorate                                                                                                               
  13\. Injecting is embarrassing                                                                                                                
  14\. Injecting is painful                                                                                                       34.1   54.8   \<0.001
  15\. Difficult to always inject correctly                                                                 40.7   57.1   0.012                 
  16\. Difficult to fulfill responsibilities                                                                                                    
  17\. Helps to control blood glucose                                                                                                           
  18\. Family/friends more concerned                                                                                                            
  19\. Helps to improve energy levels                28.4           16.4                          0.041                                         
  20\. More dependent on doctor                                                                                                                 
  Scoring                                                                                                                                       
  Total item score mean                              36.02          38.78                         0.017                                         
  Negative 16‐item score mean                        49.98          52.77                         0.014                                         
  item score mean                                                                                                                               

  Item content:                                      Counseled by doctor in last 6 months? (%)   Retinopathy? (%)   MDRD \<60? (%)                                        
  -------------------------------------------- -- -- ------------------------------------------- ------------------ ---------------- ------- ------ ------- ------ ------ -------
  1\. Failed on pre‐insulin therapy                                                                                                                                       
  2\. Diabetes has gotten worse                                                                                                                                           
  3 Prevent complications                                                                                                                                                 
  4\. Perceived by others as sicker                                                                                                                         37     54.4   0.029
  5\. Life less flexible                                                                                                                                                  
  6\. Fear of injecting with needle                                                                                                                                       
  7\. Risk of hypoglycemia                                                                                                                                                
  8\. Improves health                                                                                                                                                     
  9\. Causes weight gain                                                                                                             33.3    12.8   0.003                 
  10\. Takes time and energy                                                                                                                                              
  11\. Give up activities I enjoy                    17.1                                        34.7               0.037                                                 
  12\. My health will deteriorate                                                                                                                                         
  13\. Injecting is embarrassing                                                                                                     56.7    35.3   0.021                 
  14\. Injecting is painful                                                                                                                                               
  15\. Difficult to always inject correctly                                                                                                                               
  16\. Difficult to fulfill responsibilities                                                                                         60      37.8   0.018                 
  17\. Helps to control blood glucose                                                                                                                       58.7   74     0.033
  18\. Family/friends more concerned                                                                                                 63.3    44     0.044                 
  19\. Helps to improve energy levels                44.1                                        23.4               0.009                                                 
  20\. More dependent on doctor                                                                                                                                           
  Scoring                                                                                                                                                                 
  Total item score mean                              32.97                                       37.23              0.008                                                 
  Negative 16‐item score mean                        47.48                                       51.11              0.017            53.31   50.2   0.042                 
  Positive 4‐item score mean                         14.71                                       13.74              0.005                                                 

Only results with statistical significance at *P* ≤ 0.05 are shown. MDRD, estimated glomerular filtration rates by Modification of Diet in Renal Disease formula.
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Other results {#jdi12704-sec-0018}
-------------

Individual ITAS statements were examined for ceiling or flooring effects (i.e., \>20% of participants answering strongly agree or strongly disagree to a statement). Only ITAS question 6 showed a mild ceiling effect (21.9%).

Patients with an HbA1c \>8% were more likely to be counseled by doctors about insulin treatment (*P* ≤ 0.001). However, the majority of these patients (67.3%) did not recall having a discussion about insulin treatment with their case doctor in the previous 6 months.

When all of the participants were included, the mean total ITAS score was 36.6 (standard deviation 9.5, range 12--59), the mean negative‐scale score was 50.6 (standard deviation 9.2, range 27--73) and the mean positive‐scale score was 13.9 (standard deviation 2.1, range 7--19).

The ITAS identified different perceptions towards insulin use among different social and treatment groups. It has previously been established that psychosocial factors are important determinant factors in PIR in Asian patients[24](#jdi12704-bib-0024){ref-type="ref"} (Table[4](#jdi12704-tbl-0004){ref-type="table-wrap"}).

Discussion {#jdi12704-sec-0019}
==========

The translated C‐ITAS‐HK yielded very similar results to those of the original development study[13](#jdi12704-bib-0013){ref-type="ref"} and the only published study to re‐evaluate the psychometric performance of the ITAS[28](#jdi12704-bib-0028){ref-type="ref"}. Excluding ITAS statement 1, the current study showed a clear two‐factor structure, as in the original study. It echoed the re‐evaluation study[28](#jdi12704-bib-0028){ref-type="ref"} in showing that the ITAS cannot be better explained by a one‐factor structure, because all of the positively worded statements could not be loaded onto a single factor.

The reason that question 1 "failed on pre‐insulin therapy" could not be loaded into the two‐factor solution was not fully understood. This issue is known to be a major reason for PIR[10](#jdi12704-bib-0010){ref-type="ref"}, [29](#jdi12704-bib-0029){ref-type="ref"}. In a Taiwanese study[22](#jdi12704-bib-0022){ref-type="ref"}, question 1 "failed on pre‐insulin therapy" was scored significantly differently between insulin users and insulin‐naive patients (mean score 3.3--3.6; *P* \< 0.01). Ad hoc analysis of the results of the current study showed that the results for question 1 were not significantly different between the different treatment or characteristic groups; that is, patients with and without PIR, patients with or without complications, and patients of different social groups. This finding was unexpected, because the current C‐ITAS‐HK was modified from that used in the previous Taiwanese study[22](#jdi12704-bib-0022){ref-type="ref"}, [23](#jdi12704-bib-0023){ref-type="ref"}. The wording in the C‐ITAS‐HK was minimally changed from that in the C‐ITAS. This change was made after a pilot study in which patients expressed that they did not comprehend "signify" in Chinese. Nevertheless, retaining question 1 in the ITAS is recommended for the following reasons: first, it has been found to be a major reason for PIR in many other studies[10](#jdi12704-bib-0010){ref-type="ref"}; second, the removal of question 1 did not significantly improve internal consistency (Cronbach\'s alpha) in the total scale (0.846 to 0.844 if deleted); third, the re‐evaluation study[28](#jdi12704-bib-0028){ref-type="ref"} suggested that the results of factor analysis can differ between insulin‐naive patients and insulin users, and considering that the present study included mostly insulin‐naive diabetes mellitus patients, question 1 could still be an important factor in insulin users; finally, retaining this item allows comparison with other studies[9](#jdi12704-bib-0009){ref-type="ref"}, [13](#jdi12704-bib-0013){ref-type="ref"}, [16](#jdi12704-bib-0016){ref-type="ref"}, [17](#jdi12704-bib-0017){ref-type="ref"}, [18](#jdi12704-bib-0018){ref-type="ref"}.

In the current study and the two previous studies[13](#jdi12704-bib-0013){ref-type="ref"}, [28](#jdi12704-bib-0028){ref-type="ref"}, Cronbach\'s alpha for the whole scale was high, suggesting good internal consistency and that the removal of any statement could only minimally improve the Cronbach\'s alpha value. However, Cronbach\'s alpha for the 20‐item total scale was lower than for the 16‐item negative ITAS scale, and the positive items showed low item total correlations in the 20‐item scale. Given these results, the authors of the re‐evaluation study[28](#jdi12704-bib-0028){ref-type="ref"} suggested that "the subscale should not be combined to create a total score." Based on the results of this study, which suggest that the ITAS has a two‐factor structure, it might be more useful to calculate the positive and negative subscale scores separately than to calculate the total score. Nevertheless, in contrast to the re‐evaluation study[28](#jdi12704-bib-0028){ref-type="ref"}, the current study showed that positive statements and their subscale scores were significantly different between the treatment groups, between patients with or without PIR, and between some social groups (Tables [3](#jdi12704-tbl-0003){ref-type="table-wrap"} and [4](#jdi12704-tbl-0004){ref-type="table-wrap"}), suggesting that these items show strong discriminatory power in the study population.

PIR changes over the course of treatment, and insulin users show much lower PIR than their counterparts[13](#jdi12704-bib-0013){ref-type="ref"}, [21](#jdi12704-bib-0021){ref-type="ref"}. The ITAS showed good discriminatory power, with patients who were insulin naive and patients with PIR showing significantly higher total ITAS scores, 16‐item negative scale scores and lower four‐item positive scale scores than their counterparts (Table[3](#jdi12704-tbl-0003){ref-type="table-wrap"}).

The test--retest reliability for all 20 statements showed a positive value. However, the correlation of some statements was weak, which might have been due to the different methods of administration: the original test was self‐administered, whereas the retest was carried out by telephone interview by a trained research assistant. However, it is also possible that the C‐ITAS‐HK presented weak‐to‐moderate test--retest reliability, suggesting that patients underwent a change of attitude after administration of the questionnaire. Further research might clarify this matter. Nevertheless, the total score and the subscale scores showed good‐to‐excellent test--retest reliability (ranging from 0.692 to 0.871).

It was observed that in addition to patient PIR, physicians likely play an important role in delaying insulin treatment, as just 37% of patients showing HbA1c \>8% were counseled about insulin treatment. This phenomenon is well described[12](#jdi12704-bib-0012){ref-type="ref"}, [13](#jdi12704-bib-0013){ref-type="ref"}, [30](#jdi12704-bib-0030){ref-type="ref"}, [31](#jdi12704-bib-0031){ref-type="ref"}.

The current study used a well‐established method for the translation and validation of a transcultural questionnaire following established international guidelines. After translation, the C‐ITAS‐HK had psychometric properties similar to those described in previous studies[13](#jdi12704-bib-0013){ref-type="ref"}, [21](#jdi12704-bib-0021){ref-type="ref"}. The response rate was high, and the participants included patients from different areas of HK. In addition to examining assessment, as carried out in previous studies[13](#jdi12704-bib-0013){ref-type="ref"}, [21](#jdi12704-bib-0021){ref-type="ref"}, the present study examined the instrument\'s test--retest reliability.

The study population represented our primary care population, in which most patients were insulin naive. However, as noted in a previous study[21](#jdi12704-bib-0021){ref-type="ref"} in which the two‐factor analysis results for insulin‐naive patients and insulin users were significantly different, the extent to which the results of the current study can be generalized to patients undergoing secondary or tertiary care, where a large proportion of patients might be using insulin, is unknown.

As expected, most of the participants had a lower income level (31.2% had a family monthly income \<\$5,000), and it is not known whether the results can be applied to patients of higher socioeconomic status. However, there were no statistically significant differences in the responses to the scale among people from different social classes in the current study.

The question "will you start insulin or titrate insulin if suggested by your case doctor?" is hypothetical -- the patient might develop a different point of view when his or her illness worsens or when complications arise.

The C‐ITAS‐HK showed good psychometric properties, demonstrating its potential for primary care diabetes mellitus patients. Analyses based on the subscales might be more accurate or meaningful than those using only the total scale score.
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